Below are the most recent publications written about "Myosin Type II" by people in Profiles.
-
Hou C, Yu F, Cao C, Wang T, Pan Z, Zhong M, Liu X, Yao X, Zhang K, Yang Z, Guo J. Aurora B maintains spherical shape of mitotic cells via simultaneously stabilizing myosin II and vimentin. J Mol Cell Biol. 2025 Dec 29; 17(5).
-
Asante-Asamani E, Grange D, Rawal D, Santiago Z, Loustau J, Brazill D. A role for myosin II clusters and membrane energy in cortex rupture for Dictyostelium discoideum. PLoS One. 2022; 17(4):e0265380.
-
George Z, Omosun Y, Azenabor AA, Goldstein J, Partin J, Joseph K, Ellerson D, He Q, Eko F, McDonald MA, Reed M, Svoboda P, Stuchlik O, Pohl J, Lutter E, Bandea C, Black CM, Igietseme JU. The molecular mechanism of induction of unfolded protein response by Chlamydia. Biochem Biophys Res Commun. 2019 01 08; 508(2):421-429.
-
Berger SL, Leo-Macias A, Yuen S, Khatri L, Pfennig S, Zhang Y, Agullo-Pascual E, Caillol G, Zhu MS, Rothenberg E, Melendez-Vasquez CV, Delmar M, Leterrier C, Salzer JL. Localized Myosin II Activity Regulates Assembly and Plasticity of the Axon Initial Segment. Neuron. 2018 02 07; 97(3):555-570.e6.
-
Santiago E, Akamine P, Snider J, Wong V, Jessulat M, Deineko V, Gagarinova A, Aoki H, Minic Z, Phanse S, San Antonio A, Cubano LA, Rymond BC, Babu M, Stagljar I, Rodriguez-Medina JR. Novel Interactome of Saccharomyces cerevisiae Myosin Type?II Identified by a Modified Integrated Membrane Yeast Two-Hybrid (iMYTH) Screen. G3 (Bethesda). 2016 05 03; 6(5):1469-74.
-
Jia J, Bosley AD, Thompson A, Hoskins JW, Cheuk A, Collins I, Parikh H, Xiao Z, Ylaya K, Dzyadyk M, Cozen W, Hernandez BY, Lynch CF, Loncarek J, Altekruse SF, Zhang L, Westlake CJ, Factor VM, Thorgeirsson S, Bamlet WR, Hewitt SM, Petersen GM, Andresson T, Amundadottir LT. CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. Cancer Res. 2014 May 15; 74(10):2785-95.
-
Pag?n-Mercado G, Santiago-Cartagena E, Akamine P, Rodr?guez-Medina JR. Functional and genetic interactions of TOR in the budding yeast Saccharomyces cerevisiae with myosin type II-deficiency (myo1?). BMC Cell Biol. 2012 May 30; 13:13.
-
Wang H, Rusielewicz T, Tewari A, Leitman EM, Einheber S, Melendez-Vasquez CV. Myosin II is a negative regulator of oligodendrocyte morphological differentiation. J Neurosci Res. 2012 Aug; 90(8):1547-56.
-
Iwanicki MP, Davidowitz RA, Ng MR, Besser A, Muranen T, Merritt M, Danuser G, Ince TA, Ince T, Brugge JS. Ovarian cancer spheroids use myosin-generated force to clear the mesothelium. Cancer Discov. 2011 Jul; 1(2):144-57.
-
Vallee RB, Seale GE, Tsai JW. Emerging roles for myosin II and cytoplasmic dynein in migrating neurons and growth cones. Trends Cell Biol. 2009 Jul; 19(7):347-55.